Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Nervous System Fungal Infections”

524 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 524 results

Not applicableUnknownNCT04594785
What this trial is testing

Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection

Who this might be right for
Streptococcus PneumoniaStreptococcus Pyogenes InfectionNeisseria Meningitides Meningitis
University Hospital, Montpellier 150
Large-scale testing (Phase 3)Study completedNCT00657709
What this trial is testing

Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Who this might be right for
Serogroup B Meningococcal Meningitis
Novartis Vaccines 3,630
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Testing effectiveness (Phase 2)Study completedNCT01434680
What this trial is testing

Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis 992
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06618196
What this trial is testing

Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 336
Large-scale testing (Phase 3)Study completedNCT00255047
What this trial is testing

Safety and Immune Response of Different Pediatric Combination Vaccines.

Who this might be right for
DiphtheriaPolioPertussis
Sanofi Pasteur, a Sanofi Company 2,167
Testing effectiveness (Phase 2)Study completedNCT04031833
What this trial is testing

Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)

Who this might be right for
Cryptococcal Meningitis
Matinas BioPharma Nanotechnologies, Inc. 178
Large-scale testing (Phase 3)WithdrawnNCT03128489
What this trial is testing

Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants

Who this might be right for
DiphtheriaAcellular PertussisHaemophilus Influenzae Type b+2 more
GlaxoSmithKline
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT06482463
What this trial is testing

Diagnostic of D-lactate in Cerebrospinal Fluid Level in Patients With Suspected Ventriculostomy-related Meningitis

Who this might be right for
Nosocomial Infection
University Hospital, Toulouse 185
Not applicableStudy completedNCT03595761
What this trial is testing

Meningitis With Cerebral Vasculitis in Children

Who this might be right for
Bacterial Meningitis
University Hospital, Montpellier 17
Not applicableUnknownNCT05685641
What this trial is testing

Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City

Who this might be right for
Acquired Immunodeficiency SyndromeHistoplasmosis AIDSTuberculosis Infection+1 more
National Institute of Respiratory Diseases, Mexico 211
Large-scale testing (Phase 3)Study completedNCT03621670
What this trial is testing

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,196
Testing effectiveness (Phase 2)Study completedNCT01802502
What this trial is testing

Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation

Who this might be right for
Tuberculous Meningitis
Universitas Padjadjaran 30
Post-approval studies (Phase 4)Study completedNCT02853929
What this trial is testing

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Who this might be right for
DiphtheriaHepatitis BAcellular Pertussis+4 more
GlaxoSmithKline 551
Testing effectiveness (Phase 2)Study completedNCT00310856
What this trial is testing

Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)

Who this might be right for
Meningococcal Meningitis
Novartis Vaccines 175
Post-approval studies (Phase 4)Study completedNCT00635128
What this trial is testing

Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

Who this might be right for
PoliomyelitisDiphtheriaTetanus+1 more
GlaxoSmithKline 415
Testing effectiveness (Phase 2)Study completedNCT00307567
What this trial is testing

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Who this might be right for
Acellular PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 689
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Load More Results